J. Marksteiner

H. Hinterhuber, S. Mechtcheriakov, J. Marksteiner, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Neuropsychologie in der Demenzdiagnostik

J. Marksteiner, T. Bodner, C. Jenner, 2002 .

Second-Generation Antipsychotics

E. Weiss, J. Marksteiner, W. Aichhorn, 2006, Drug safety.

Glial cell line-derived neurotrophic factor enhances survival of GM-CSF dependent rat GMIR1-microglial cells

C. Humpel, C. Weis, J. Marksteiner, 2002, Neuroscience Research.

Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human brain stem

H. Hinterhuber, J. Marksteiner, A. Saria, 1994, Journal of Chemical Neuroanatomy.

Increased Acetylation of Histone H4 at Lysine 12 (H4K12) in Monocytes of Transgenic Alzheimer's Mice and in Human Patients.

C. Humpel, J. Marksteiner, B. Plagg, 2015, Current Alzheimer research.

Second-Generation Antipsychotics

E. Weiss, J. Marksteiner, W. Aichhorn, 2006, Drug safety.

Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment

J. Feldon, A. Laslop, W. Fleischhacker, 2001, Neuroscience.

Distribution of catestatin-like immunoreactivity in the human auditory system

J. Marksteiner, S. Mahata, M. Bitsche, 2003, Hearing Research.

Reduced beta-amyloid sensitivity for platelet–monocyte aggregates in EDTA blood of alzheimer patients

C. Humpel, J. Marksteiner, M. Defrancesco, 2017, International Psychogeriatrics.

Current issues and open questions for future research

M. Aster, J. Marksteiner, L. Kaufmann, 2020 .

GDNF and TGF-β1 promote cell survival in serum-free cultures of primary rat microglia

C. Humpel, J. Marksteiner, M. Reindl, 2003, Cell and Tissue Research.

Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations

C. Humpel, J. Marksteiner, B. Hutter-Paier, 2007, Brain Research.

Enhanced Rate of Expression and Biosynthesis of Neuropeptide Y After Kainic Acid‐Induced Seizures

G. Sperk, J. Marksteiner, D. K. Meyer, 1991, Journal of neurochemistry.

NGF but not GDNF or neurturin enhance acetylcholine tissue levels in striatal organotypic brain slices

C. Humpel, J. Marksteiner, G. Ransmayr, 1998, International Journal of Developmental Neuroscience.

Distribution and Processing of Secretoneurin in the Developing Rat Brain a

J. Marksteiner, W. Kaufmann, A. Saria, 1997, Annals of the New York Academy of Sciences.

Ontogenic development of secretogranin II and of its processing to secretoneurin in rat brain.

J. Marksteiner, W. Kaufmann, A. Saria, 1997, Brain research. Developmental brain research.

PE-11, a peptide derived from chromogranin B, in the human brain

J. Marksteiner, W. Kaufmann, H. Maier, 1999, Neuroscience.

Obstructive Ileus of Large Bowel Is Associated with Low Tissue Levels of Neuropeptides in Prestenotic Bowel Segment

G. Wetscher, J. Marksteiner, A. Saria, 1997, Digestive Diseases and Sciences.

Obstructive ileus of the large bowel is associated with low tissue levels of neuropeptides in the prestenotic bowel segment

G. Wetscher, J. Marksteiner, A. Saria, 1995 .

Human and Rat Primary C‐Fibre Afferents Store and Release Secretoneurin, a Novel Neuropeptide

J. Marksteiner, S. Mahata, M. Mahata, 1994, The European journal of neuroscience.

Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparison with that of substance P and calcitonin gene‐related peptide

J. Marksteiner, S. Mahata, M. Mahata, 1994, The Journal of comparative neurology.

Addiction in the time of COVID-19: Longitudinal course of substance use, psychological distress, and loneliness among a transnational Tyrolean sample with substance use disorders

C. Haring, A. Hofer, A. Conca, 2022, Frontiers in Psychiatry.

Distribution of mRNAs for Chromogranins A and B and Secretogranin II in Rat Brain

G. Sperk, J. Marksteiner, M. Mahata, 1991, The European journal of neuroscience.

Reply to Croes et al.

R. Nitsch, C. Hock, G. Binetti, 2000 .

Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human spinal cord

S. Telser, H. Hinterhuber, J. Marksteiner, 1995, Neuroscience Letters.

Motor dysfunction in patients with liver cirrhosis: impairment of handwriting

H. Hinterhuber, S. Mechtcheriakov, J. Marksteiner, 2006, Journal of Neurology.

Chromogranins in rat brain: characterization, topographical distribution and regulation of synthesis

G. Sperk, J. Marksteiner, R. Fischer‐Colbrie, 1990, Brain Research.

Chromogranin peptides in amyotrophic lateral sclerosis

C. Walcher, C. Humpel, J. Marksteiner, 2009, Regulatory Peptides.

K. Seppi, J. Marksteiner, H. Knaus, 2018, Brain Structure and Function.

Catestatin--a novel neuropeptide in carcinoid tumors of the appendix.

J. Marksteiner, S. Mahata, R. Margreiter, 2004, Anticancer research.

Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid Angiopathy

C. Humpel, J. Marksteiner, H. Oberacher, 2020, Frontiers in Neurology.

Chromogranin peptides in brain diseases

K. Jellinger, J. Marksteiner, Michael Willis, 2011, Journal of Neural Transmission.

Abnormalities of Amyloid β Precursor Protein Expression in Platelets of Patients With Alzheimer Disease: Do We Understand Them Well Enough?—Reply

J. Marksteiner, F. Marx, I. Blasko, 1999 .

[Gender differences in cognitive functions].

H. Hinterhuber, E. Weiss, J. Marksteiner, 2005, Fortschritte der Neurologie-Psychiatrie.

Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.

H. Hinterhuber, S. Mechtcheriakov, J. Marksteiner, 2005, World journal of gastroenterology.

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease

C. Humpel, J. Marksteiner, M. Defrancesco, 2022, Frontiers in Aging Neuroscience.

Further Evidence that Behavioral Tests and Neuropeptide mRNA and Tissue Level Alterations Can Differentiate between Typical and Atypical Antipsychotic Drugs

I. Kilpatrick, W. Fleischhacker, J. Marksteiner, 2000, Neuropsychopharmacology.

Child and adolescent psychiatry patients coming of age: a retrospective longitudinal study of inpatient treatment in Tyrol

C. Haring, G. Kemmler, A. Hausmann, 2016, BMC Psychiatry.

[Quality of life in mild cognitive impairment, patients with different stages of Alzheimer disease and healthy control subjects].

I. Papousek, A. Fink, E. Weiss, 2012, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Neuropeptide Levels after Pentylenetetrazol Kindling in the Rat

G. Sperk, H. Lassmann, C. Humpel, 1990, The European journal of neuroscience.

Molecular characterization of immunoreactivities of peptides derived from chromogranin a (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid

J. Marksteiner, R. Kirchmair, A. Saria, 1994, Neuroscience.

Monocyte migration: a novel effect and signaling pathways of catestatin.

J. Marksteiner, S. Mahata, R. Kirchmair, 2008, European journal of pharmacology.

Pronounced increases in brain levels of calcitonin gene-related peptide after kainic acid induced seizures

G. Sperk, C. Humpel, J. Marksteiner, 1989, Regulatory Peptides.

Cerebrovascular damage as a cause for Alzheimer's disease.

C. Humpel, J. Marksteiner, 2005, Current neurovascular research.

Concentrations of mRNAs encoding for preprosomatostatin and preprocholecystokinin are increased after kainic acid‐induced seizures

G. Sperk, G. Sperk, J. Marksteiner, 1989, Synapse.

Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers

J. Marksteiner, R. Kirchmair, A. Saria, 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

Localization of neuroendocrine secretory protein 55 messenger RNA in the rat brain

J. Marksteiner, I. Kapeller, R. Fischer-Colbrie, 1999, Neuroscience.

Differential Changes in Tachykinins in the Rat Brain after Drug‐induced Seizures a

G. Sperk, C. Humpel, J. Marksteiner, 1991, Annals of the New York Academy of Sciences.

Differential changes in tachykinins after kainic acid-induced seizures in the rat

G. Sperk, C. Humpel, J. Marksteiner, 1990, Neuroscience.

Differential changes in mRNAs encoding for preprotachykinin A and B after kainic acid‐induced seizures in the rat

G. Sperk, C. Humpel, J. Marksteiner, 1991, Synapse.

K. Seppi, J. Marksteiner, H. Knaus, 2018, Brain Structure and Function.

C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients

P. Fischer, J. Marksteiner, H. Sutterlüty, 2022, Neurobiology of Disease.

Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations

G. Kemmler, J. Marksteiner, W. Aichhorn, 2006, International clinical psychopharmacology.

Effects of Age and Sex on Olanzapine Plasma Concentrations

G. Kemmler, J. Marksteiner, W. Aichhorn, 2005, Journal of clinical psychopharmacology.

Influence of age and gender on risperidone plasma concentrations

G. Kemmler, J. Marksteiner, Renate Stelzig-Schoeler, 2005, Journal of psychopharmacology.

Fighting stigma of mental illness in midsize European countries

J. A. Boer, E. Seifritz, B. Gillain, 2012, Social Psychiatry and Psychiatric Epidemiology.

Persistent Cognitive Deficits Associated with Lithium Intoxication: A Neuropsychological Case Description

J. Marksteiner, T. Benke, L. Bartha, 2002, Cortex.

Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry

M. Schocke, E. Weiss, S. Mechtcheriakov, 2008, Psychiatry Research: Neuroimaging.

Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects.

C. Kohler, H. Hinterhuber, G. Kemmler, 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Concomitant increase of somatostatin, neuropeptide y and glutamate decar☐ylase in the frontal cortex of rats with decreased seizure threshold

G. Sperk, J. Marksteiner, 1988, Neuroscience.

Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.

D. Fuchs, G. Kemmler, A. Griesmacher, 2007, Journal of psychiatric research.

Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer’s Disease

M. Schocke, H. Hinterhuber, J. Marksteiner, 2014, PloS one.

Muscarinic Cholinergic Receptor Agonists and Antagonists

C. Buhusi, P. Shizgal, T. Robbins, 2015 .

Subacute dementia and imaging correlates in a case of Fahr’s disease

M. Delazer, K. Seppi, J. Marksteiner, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[Alcohol induced cognitive deficits].

E. Weiss, J. Marksteiner, Beatrix Ruepp, 2014, Wiener medizinische Wochenschrift.

State of Acute Agitation at Psychiatric Emergencies in Europe: The STAGE Study

L. San, P. Zwanzger, J. Marksteiner, 2016, Clinical practice and epidemiology in mental health : CP & EMH.

High Frequency of Mutations in Four Different Disease Genes in Early‐Onset Dementia

R. Nitsch, C. Hock, P. Sonderegger, 2000, Annals of the New York Academy of Sciences.

High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

R. Nitsch, C. Hock, G. Binetti, 2000, American journal of human genetics.

The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla

A. Laslop, J. Marksteiner, R. Fischer‐Colbrie, 1999, Neuroscience Letters.

Rat Brain: Distribution of Immunoreactivity of PE‐11, a Peptide Derived from Chromogranin B

J. Marksteiner, R. Fischer‐Colbrie, H. Winkler, 1996, The European journal of neuroscience.

L-type calcium channel CaV 1.2 in transgenic mice overexpressing human AbetaPP751 with the London (V717I) and Swedish (K670M/N671L) mutations.

F. Hofmann, C. Humpel, J. Marksteiner, 2010, Journal of Alzheimer's disease : JAD.

Distribution of neurons expressing neurokinin B in the rat brain: Immunohistochemistry and in situ hybridization

G. Sperk, J. Marksteiner, J. Krause, 1992, The Journal of comparative neurology.

Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert

C. Humpel, C. Weis, J. Marksteiner, 2001, Neuroscience.

Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy of the rat

G. Sperk, J. Marksteiner, M. Ortler, 1990, Neuroscience Letters.

Telomere length is age-dependent and reduced in monocytes of Alzheimer patients

C. Humpel, J. Marksteiner, T. Hochstrasser, 2012, Experimental Gerontology.

The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

G. Kemmler, C. Humpel, J. Marksteiner, 2015, Alzheimer's & dementia.

Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease

G. Kemmler, C. Humpel, J. Marksteiner, 2017, Metabolomics.

Treatment Strategies in Alzheimer’s Disease with a Focus on Early Pharmacological Interventions

R. Schmidt, J. Marksteiner, R. Schmidt, 2004, Drugs & aging.

Platelets in the Alzheimer's Disease Brain: do they Play a Role in Cerebral Amyloid Angiopathy?

C. Humpel, J. Marksteiner, D. Ehrlich, 2015, Current neurovascular research.

Explicit (Semantic) Memory for Music in Patients with Mild Cognitive Impairment and Early-Stage Alzheimer's Disease

G. Mazzola, H. Hinterhuber, G. Kemmler, 2013, Experimental aging research.

Dietary spermidine improves cognitive function.

H. Tilg, L. Scorrano, G. Kroemer, 2021, Cell reports.

What Characterizes Depression in Old Age? Results from the Bruneck Study

S. Kiechl, J. Willeit, H. Hinterhuber, 2017, Pharmacopsychiatry.

Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.

H. Hinterhuber, G. Kemmler, J. Marksteiner, 2007, Journal of child and adolescent psychopharmacology.

Bright ambient light conditions reduce the effect of tryptophan depletion in healthy females

H. Hinterhuber, W. Parson, G. Kemmler, 2013, Psychiatry Research.

CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.

Nina Daschil, C. Humpel, G. Obermair, 2013, Journal of Alzheimer's disease : JAD.

Platelet dysfunction in hypercholesterolemia mice, two Alzheimer’s disease mouse models and in human patients with Alzheimer’s disease

C. Humpel, J. Marksteiner, B. Plagg, 2015, Biogerontology.

Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease.

C. Humpel, J. Marksteiner, 2013, Current neurovascular research.

Matrix metalloproteinase-2 and epidermal growth factor are decreased in platelets of Alzheimer patients.

C. Humpel, J. Marksteiner, B. Sperner-Unterweger, 2012, Current Alzheimer research.

Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer's Disease as Identified by Targeted Metabolomics.

C. Humpel, J. Marksteiner, H. Oberacher, 2019, Journal of Alzheimer's disease : JAD.

Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?

C. Humpel, C. Linhart, J. Marksteiner, 2017, Journal of Alzheimer's disease : JAD.

Acute effects of outdoor physical activity on affect and psychological well-being in depressed patients – A preliminary study

J. Marksteiner, M. Kopp, M. Niedermeier, 2016 .

Differential effect of catechol-O-methyltransferase Val158Met genotype on emotional recognition abilities in healthy men and women

Herbert Oberacher, Georg Kemmler, Walther Parson, 2007, Journal of the International Neuropsychological Society.

Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease

C. Humpel, J. Marksteiner, M. Pirchl, 2006, Neurological research.

L-type calcium channel blockers and substance P induce angiogenesis of cortical vessels associated with beta-amyloid plaques in an Alzheimer mouse model

Nina Daschil, C. Humpel, G. Obermair, 2015, Neurobiology of Aging.

Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study

G. Kemmler, C. Humpel, J. Marksteiner, 2014, Experimental Gerontology.

[Differences between men and women in side effects of second-generation antipsychotics].

H. Hinterhuber, E. Weiss, J. Marksteiner, 2007, Der Nervenarzt.

Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs

E. Weiss, J. Marksteiner, W. Aichhorn, 2005 .

Fear acquisition and extinction deficits in amnestic mild cognitive impairment and early Alzheimer's disease

F. Wilhelm, M. Liedlgruber, J. Marksteiner, 2019, Neurobiology of Aging.

Beta-amyloid expression, release and extracellular deposition in aged rat brain slices

C. Humpel, J. Marksteiner, Josef Marksteiner, 2008, Molecular Psychiatry.

Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

G. Kemmler, J. Marksteiner, E. Deisenhammer, 2017, Journal of Alzheimer's disease : JAD.

Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease

G. Kemmler, C. Humpel, J. Marksteiner, 2021, Experimental Gerontology.

[Association of Mild Cognitive Impairment (MCI) and depression].

H. Hinterhuber, E. Weiss, J. Marksteiner, 2009, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Loneliness and Burden Perceived by Family Caregivers of Patients With Alzheimer Disease

K. Moeller, J. Marksteiner, L. Kaufmann, 2020, American journal of Alzheimer's disease and other dementias.

Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.

A. Futschik, R. Schmidt, S. Seiler, 2018, Journal of Alzheimer's disease : JAD.

Predictors of patient dependence in mild-to-moderate Alzheimer's disease.

R. Schmidt, J. Marksteiner, T. Benke, 2014, Journal of Alzheimer's disease : JAD.

Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patients.

C. Humpel, J. Marksteiner, S. Mahata, 2008, Journal of Alzheimer's disease : JAD.

Chromogranin peptides in Alzheimer's disease

Christian Humpel, K. Jellinger, C. Humpel, 2004, Experimental Gerontology.

The CERAD Neuropsychological Assessment Battery Is Sensitive to Alcohol-Related Cognitive Deficiencies in Elderly Patients: A Retrospective Matched Case-Control Study

K. Moeller, S. Huber, J. Marksteiner, 2017, Journal of the International Neuropsychological Society.

Synaptic proteins in Alzheimer’s disease

C. Humpel, J. Marksteiner, W. Kaufmann, 2002, Journal of Molecular Neuroscience.

Temporal lobe epilepsy of the rat: differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfields of the hippocampus

G. Sperk, J. Marksteiner, S. Mahata, 1992 .

Differential effects of phencyclidine application on secretogranin II expression in organotypic slices of rat prefrontal cortex

W. Fleischhacker, C. Humpel, J. Marksteiner, 2003, Journal of neurochemistry.

First localization and biochemical identification of chromogranin B- and secretoneurin-like immunoreactivity in the fetal human vagal/nucleus solitary complex

C. Humpel, J. Marksteiner, M. Bitsche, 2006, Regulatory Peptides.

Stigma in Midsize European Countries

J. Marksteiner, M. Figueira, M. Jarema, 2017 .

Synaptic loss reflected by secretoneurin‐like immunoreactivity in the human hippocampus in Alzheimer's disease

H. Hinterhuber, C. Humpel, J. Marksteiner, 1998, The European journal of neuroscience.

Efficacy of Donepezil Treatment in Alzheimer Patients with and without Subcortical Vascular Lesions

A. Monsch, H. Hinterhuber, J. Marksteiner, 2004, Pharmacology.

The Mediating Role of Resilience and Extraversion on Psychological Distress and Loneliness Among the General Population of Tyrol, Austria Between the First and the Second Wave of the COVID-19 Pandemic

C. Haring, G. Kemmler, A. Hofer, 2021, Frontiers in Psychiatry.

Therapieadhärenz bei Schizophrenie-Patienten

A. Erfurth, W. Wolfgang Fleischhacker, J. Marksteiner, 2011 .

Mesencephalic grafts increase preprotachykinin-A mRNA expression in striatal grafts in an in oculo co-graft model

I. Strömberg, C. Humpel, J. Marksteiner, 1995, Regulatory Peptides.

Assessment of Fractal Characteristics of Locomotor Activity of Geriatric In-Patients With Alzheimer’s Dementia

Pierre Sachse, Wilfried Pohl, Elisabeth M. Weiss, 2019, Front. Aging Neurosci..

Decision Making under Risk in Patients Suffering from Schizophrenia or Depression

L. Zamarian, E. Weiss, J. Marksteiner, 2021, Brain sciences.

Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain

J. Marksteiner, H. Knaus, G. Wietzorrek, 2016, Brain Structure and Function.

Comparative immunohistochemical distribution of three small-conductance Ca2+-activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain

J. Marksteiner, W. Kaufmann, C. Sailer, 2004, Molecular and Cellular Neuroscience.

Disorder-Specific Profiles of Self-Perceived Emotional Abilities in Schizophrenia and Major Depressive Disorder

I. Papousek, A. Fink, M. Canazei, 2022, Brain sciences.

[Problems of pain measurement and pain therapy in the elderly].

J. Marksteiner, P. Pietschmann, M. Friedrich, 2010, Wiener medizinische Wochenschrift.

Networks of Depression and Cognition in Elderly Psychiatric Patients

Erik Danay, J. Marksteiner, G. Brauchle, 2017 .

Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat

G. Sperk, J. Marksteiner, M. Mahata, 1992, Neuroscience.

Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain

J. Marksteiner, S. Mahata, M. Mahata, 1995, Neuroscience.

Future Perspectives in Antipsychotic Drug Development

W. Fleischhacker, J. Marksteiner, 2000 .

Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodies

W. Poewe, M. Schocke, K. Seppi, 2004, Neuroreport.

Platelet TAU is Associated with Changes in Depression and Alzheimer's Disease.

B. Sarg, C. Humpel, J. Marksteiner, 2022, Frontiers in Bioscience.

Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease

W. Poewe, K. Seppi, G. Wenning, 2001, European Journal of Nuclear Medicine.

Psychophysiological Effects of a Single, Short, and Moderately Bright Room Light Exposure on Mildly Depressed Geriatric Inpatients: A Pilot Study

H. Lackner, I. Papousek, M. Canazei, 2017, Gerontology.

Fear acquisition and extinction in elderly patients with depression.

F. Wilhelm, J. Marksteiner, H. Bliem, 2020, Journal of affective disorders.

EEG-neurofeedback as a training method for cognitive and non-cognitive functions in early dementia: A case report

S. Kober, Guilherme Maia de Oliveira Wood, J. Marksteiner, 2019, Lernen und Lernstörungen.

Mental health in individuals with severe mental disorders during the covid-19 pandemic: a longitudinal investigation

C. Haring, M. Huber, A. Hofer, 2022, Schizophrenia.

Differences in psychological and somatic symptom cluster score profiles between subjects with Idiopathic environmental intolerance, major depression and schizophrenia

I. Papousek, H. Kapfhammer, E. Weiss, 2017, Psychiatry Research.

Auditory top-down control and affective theory of mind in schizophrenia with and without hallucinations

I. Papousek, A. Fink, E. Weiss, 2016, Schizophrenia Research.

Co-distribution patterns of chromogranin B-like immunoreactivity with chromogranin A and secretoneurin within the human brainstem

C. Humpel, J. Marksteiner, A. Schrott-Fischer, 2000, Brain Research.

Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias

H. Hinterhuber, G. Kemmler, C. Humpel, 2005, Dementia and Geriatric Cognitive Disorders.

Fighting stigma of mental illness in midsize European countries

B. Gillain, J. Prasko, J. Marksteiner, 2012, Social psychiatry and psychiatric epidemiology.

Gender-Specific Differences in Cognitive Profiles of Patients with Alzheimer's Disease: Results of the Prospective Dementia Registry Austria (PRODEM-Austria).

R. Schmidt, J. Marksteiner, T. Benke, 2015, Journal of Alzheimer's disease : JAD.

Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).

R. Schmidt, Y. Höller, G. Kemmler, 2019, Journal of Alzheimer's disease : JAD.

Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature

J. Marksteiner, M. Defrancesco, W. Fleischhacker, 2015, The international journal of neuropsychopharmacology.

Peripheral Biomarkers in Dementia and Alzheimer's Disease

C. Humpel, J. Marksteiner, 2009 .

Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy

Michael Schocke, Wolfgang Vogel, M. Schocke, 2005, Neuroradiology.

Clock Drawing, Clock Reading, Clock Setting, and Judgment of Clock Faces in Elderly People with Dementia and Depression

M. Delazer, G. Kemmler, J. Marksteiner, 2004, Journal of the American Geriatrics Society.

Diagnostic value of fine motor deficits in patients with low-grade hepatic encephalopathy.

H. Hinterhuber, M. Rettenbacher, S. Mechtcheriakov, 2005, World journal of gastroenterology.

Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects

G. Kemmler, C. Humpel, J. Marksteiner, 2011, Dementia and Geriatric Cognitive Disorders Extra.

Analysis of Cerebrospinal Fluid of Alzheimer Patients

H. Hinterhuber, C. Humpel, J. Marksteiner, 2008, Pharmacology.

Effects of dynamic bedroom lighting on measures of sleep and circadian rest-activity rhythm in inpatients with major depressive disorder

M. Canazei, E. Weiss, J. Marksteiner, 2022, Scientific Reports.

Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues.

J. Marksteiner, R. Kirchmair, R. Fischer‐Colbrie, 1995, The Biochemical journal.

Leichte kognitive Beeinträchtigung mit Vorzeichen rascher Verschlechterung

J. Pantel, Hans Förstl, A. Kurz, 2008, Deutsche medizinische Wochenschrift.

Cognition, gender, and functional abilities in Alzheimer's disease: how are they related?

R. Schmidt, H. Schmidt, F. Leblhuber, 2013, Journal of Alzheimer's disease : JAD.

Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.

J. Marksteiner, C. Jagsch, E. Windhager, 2007, Pharmacopsychiatry.

Dkk‐3 is elevated in CSF and plasma of Alzheimer’s disease patients

C. Humpel, J. Marksteiner, P. Berger, 2009, Journal of neurochemistry.

Experience of stigma and discrimination reported by people experiencing the first episode of schizophrenia and those with a first episode of depression: The FEDORA project

G. Thornicroft, J. Marksteiner, M. Jarema, 2015, The International journal of social psychiatry.

Limbic seizures cause pronounced changes in the expression of neurokinin B in the hippocampus of the rat

G. Sperk, J. Marksteiner, J. Krause, 1992, Neuroscience.

Psychological Distress, Loneliness, and Boredom Among the General Population of Tyrol, Austria During the COVID-19 Pandemic

C. Haring, G. Kemmler, A. Hofer, 2021, Frontiers in Psychiatry.

Happy and Sad Judgements in Dependence on Mode and Note Density in Patients with Mild Cognitive Impairment and Early-Stage Alzheimer's Disease

H. Hinterhuber, G. Kemmler, E. Weiss, 2014, Gerontology.

[Working memory for music in patients with mild cognitive impairment and early stage Alzheimer's disease].

G. Mazzola, H. Hinterhuber, G. Kemmler, 2013, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Glial-cell-line-derived neurotrophic factor enhances biosynthesis of substance P in striatal neurons in vitro

C. Humpel, J. Marksteiner, A. Saria, 1996, Cell and Tissue Research.

Alcohol induced disorders

J. Marksteiner, P. Mikosch, 2014, Wiener Medizinische Wochenschrift.

Cardiovascular Variability and Reactivity in Major Depressive Disorder

S. Duschek, J. Marksteiner, G. R. D. Paso, 2021 .

Features of autonomic cardiovascular control during cognition in major depressive disorder.

S. Duschek, U. Ettinger, J. Marksteiner, 2020, Psychophysiology.

Much is Known about Caregiver Burden in Dementia - What is Next? The Role of Comorb idities and Future Perspectives

Andreas, Thomas, J. Marksteiner, 2021, Journal of Experimental Neurology.

Brief Report: CANTAB Performance and Brain Structure in Pediatric Patients with Asperger Syndrome

M. Schocke, E. Weiss, J. Marksteiner, 2013, Journal of autism and developmental disorders.

The Impact of Resilience and Extraversion on Psychological Distress, Loneliness, and Boredom During the COVID-19 Pandemic: A Follow-Up Study Among the General Population of Tyrol, Austria

C. Haring, G. Kemmler, A. Hofer, 2021, Frontiers in Psychiatry.

Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.

M. Schocke, G. Kemmler, J. Marksteiner, 2013, Journal of Alzheimer's disease : JAD.

Pain and Associated Neuropsychiatric Symptoms in Patients Suffering from Dementia: Challenges at Different Levels and Proposal of a Conceptual Framework

K. Moeller, J. Marksteiner, L. Kaufmann, 2021, Journal of Alzheimer's disease : JAD.

Distribution of Secretoneurin‐like Immunoreactivity in Comparison with Substance P‐ and Enkephalin‐like Immunoreactivities in Various Human Forebrain Regions

J. Marksteiner, G. Ransmayr, R. Kirchmair, 1993, The European journal of neuroscience.

Presence and distribution of a new neuropeptide, secretoneurin, in human retina

J. Marksteiner, R. Kirchmair, A. Saria, 1996, Peptides.

Neurochemical compartments in the human forebrain: Evidence for a high density of secretoneurin‐like immunoreactivity in the extended amygdala

G. Alheid, J. Marksteiner, W. Kaufmann, 1997, Synapse.

Evidence for a high density of secretoneurin‐like immunoreactivit in the extended amygdala of the rat

S. Telser, J. Marksteiner, R. Kirchmair, 1995, The Journal of comparative neurology.

Comparative distribution of neurokinin B-, substance P- and enkephalin-like immunoreactivities and neurokinin B messenger RNA in the basal forebrain of the rat: Evidence for neurochemical compartmentation

J. Marksteiner, J. Krause, A. Saria, 1992, Neuroscience.

Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat

G. Sperk, J. Marksteiner, D. Maas, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Genetische Grundlagen der Posttraumatischen Belastungsstörung (PTBS)

W. Parson, E. Weiss, J. Marksteiner, 2018, PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie.

Secretoneurin: A marker in rat hippocampal pathways

G. Sperk, C. Schwarzer, J. Marksteiner, 1997, The Journal of comparative neurology.

Ubiquitin enzymes, ubiquitin and proteasome activity in blood mononuclear cells of MCI, Alzheimer and Parkinson patients.

C. Humpel, J. Marksteiner, C. Ullrich, 2010, Current Alzheimer research.

Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain: An immunocytochemical and radioimmunological study

J. Marksteiner, S. Mahata, M. Mahata, 1993, Neuroscience.

Temporal lobe epilepsy of the rat: differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfield of the hippocampus.

G. Sperk, J. Marksteiner, S. Mahata, 1992, Brain research. Molecular brain research.

Magnetic stimulation induces neuronal c-fos via tetrodotoxin-sensitive sodium channels in organotypic cortex brain slices of the rat

H. Hinterhuber, C. Humpel, A. Hausmann, 2001, Neuroscience Letters.

Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer’s disease

K. Jellinger, C. Humpel, J. Marksteiner, 2000, Acta Neuropathologica.

Direct molecular haplotyping of multiple polymorphisms within exon 4 of the human catechol-O-methyltransferase gene by liquid chromatography–electrospray ionization time-of-flight mass spectrometry

W. Parson, E. Weiss, J. Marksteiner, 2006, Analytical and bioanalytical chemistry.

Effect of anticonvulsant treatment on kainic acid-induced increases in peptide levels.

G. Sperk, J. Marksteiner, R. Prommegger, 1990, European journal of pharmacology.

Pharmacological treatment strategies of residential primary care providers in dementia diseases--results of a representative survey in western Austria.

H. Hinterhuber, G. Kemmler, J. Marksteiner, 2002, Pharmacopsychiatry.

[Therapy of Alzheimer's disease: current status and future development].

R. Schmidt, R. Dodel, F. Reisecker, 2008, Neuropsychiatrie (Deisenhofen).

Compartmentation of alpha 1 and alpha 2 GABAA receptor subunits within rat extended amygdala: implications for benzodiazepine action

G. Alheid, C. Humpel, J. Marksteiner, 2003, Brain Research.

[Pain measurement in cognitively impaired patients with the Doloshort scale].

J. Marksteiner, R. Likar, G. Pinter, 2015, Schmerz.

Serial Position Effects in Patients with Mild Cognitive Impairment and Early and Moderate Alzheimer's Disease Compared with Healthy Comparison Subjects

I. Papousek, A. Fink, E. Weiss, 2013, Dementia and Geriatric Cognitive Disorders.

[Sex differences in Alzheimer's disease].

K. Jellinger, H. Schmidt, G. Ladurner, 2008, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment

C. Humpel, E. Weiss, J. Marksteiner, 2010, Experimental Gerontology.

[Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors].

M. Schocke, H. Hinterhuber, E. Weiss, 2010, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

What Characterizes Depression in Old Age? Results from the Bruneck Study

S. Kiechl, J. Willeit, H. Hinterhuber, 2017, Pharmacopsychiatry.

Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.

A. Futschik, S. Seiler, J. Marksteiner, 2018, Journal of Alzheimer's disease : JAD.

Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry

M. Schocke, E. Weiss, S. Mechtcheriakov, 2008, Psychiatry Research: Neuroimaging.

Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.

G. Kemmler, J. Marksteiner, A. Lingg, 2003, The Journal of clinical psychiatry.

L-type calcium channel blockers and substance P induce angiogenesis of cortical vessels associated with beta-amyloid plaques in an Alzheimer mouse model

Nina Daschil, C. Humpel, G. Obermair, 2015, Neurobiology of Aging.

Evaluating Performance and Interpretability of Machine Learning Methods for Predicting Delirium in Gerontopsychiatric Patients

Elske Ammenwerth, Werner O. Hackl, Michael Netzer, 2020, dHealth.

Analysis of Cerebrospinal Fluid of Alzheimer Patients

H. Hinterhuber, C. Humpel, J. Marksteiner, 2008, Pharmacology.

[Position paper of the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies].

H. Hinterhuber, J. Marksteiner, P. Dal-Bianco, 2020, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Neuropeptide Y expression in animal models of temporal lobe epilepsy.

G. Sperk, J. Marksteiner, S. Greber, 1996, Epilepsy research. Supplement.

Differential increases of neurokinin B- and enkephalin-like immunoreactivities and their mRNAs after chronic haloperidol treatment in the rat

J. Marksteiner, J. Krause, A. Saria, 1992, Neuroscience Letters.